Mark Duggan is an expert in health economics. His research areas include Traditional Medicare, Medicare Advantage, Medicaid, disability insurance, the Affordable Care Act, pharmaceutical and hospital pricing, health insurance pricing, and patent reform. He has consulted and testified on matters related to the False Claims Act, reimbursement disputes between payors and providers, healthcare competition, pharmaceutical pricing, and pharmaceutical competition. Professor Duggan has deposition testimony experience.
Professor Duggan was the 2010 recipient of the ASHEcon Medal, awarded every two years by the American Society of Health Economists to the economist aged forty and under in the U.S. who has made the most significant contributions to the field of health economics. Along with his coauthor, he received the National Institute for Health Care Management’s 2011 Health Care Research Award for their work on Medicare Part D.
From 2015 to 2024, Professor Duggan served as the Trione Director of the Stanford Institute for Economic Policy Research (SIEPR). From 2009 to 2010, he was the senior economist for healthcare policy at the President’s Council of Economic Advisers. He has received several awards for his teaching.
Professor Duggan has coedited the American Economic Journal: Economic Policy and the Journal of Public Economics. Prior to his position at Stanford, he served on the faculty at the Wharton School of the University of Pennsylvania, and in the economics departments at the University of Chicago and the University of Maryland.